WHO ICTRP trial
Effect of mesenchymal stem cells on healing of foot ulcers in diabetes patients…
CTIS2023-505961-10-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-505961-10-00 |
|---|---|
| Public title | Effect of mesenchymal stem cells on healing of foot ulcers in diabetes patients. A phase I pilot study. |
| Scientific title | Effect of mesenchymal stem cells on healing of foot ulcers in diabetes patients. A phase I pilot study. - STEMFOOT |
| Primary sponsor | Cell2cure ApS |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use - (Phase IV): no |
| Countries | Denmark |
| Conditions | Diabetic foot ulcus MedDRA version: 21.1Level: LLTClassification code: 10012664Term: Diabetic foot ulcerSystem Organ Class: 10040785;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17];MedDRA version: 21.1Level… |
| Interventions | Product Name: C2C_ASC2210,Product Code: PRD10375703,Pharmaceutical Form: CONCENTRATE AND SOLVENT FOR DISPERSION FOR INJECTION,Other descriptive name: ,Strength: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded… |
| Registration date | May 30, 2023 |
| Target size | 30 |
| Secondary IDs | 2022-001589-37;NCT05595681 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: